Earnings release
Page 1
PHARMANUTRA Teleborsa : distribution and commercial use strictly prohibited emarket sdir storage CERTIFIED PHARMANUTRA S.P.A .: THE BOARD OF DIRECTORS APPROVES THE HALF - YEAR FINANCIAL REPORT AS OF JUNE 30TH 2026 The Group steady growth continues , driven by the great performance from international markets and flagship products ■ Consolidated Sales Revenues € 73 M ( + 17.9 % versus 06/30/2025 ) EBITDA € 17.5 M ( + 6.2 % versus 06/30/2025 ) Net Result for the period € 9.9 M ( + 8.1 % versus 06/30/2025 ) " Net Financial Position € - 2.9 M ( vs € 11.4 M at 12/31/2025 ) Pisa , September 11th , 2026 - The Board of Directors of Pharmanutra S.p.A. ( MTA ; Ticker PHN ) , a company specializing in mineral - based nutritional supplements and medical devices for muscles and joints , today approved the Half - Year Financial Report as at 30 June 2026 , subject to limited audit . Roberto Lacorte , Vice President and CEO of Pharmanutra S.p.A. , commented : " It is a great satisfaction to share with all our stakeholders the results for the first half of the year , which confirm the solid and continuous growth of the Pharmanutra Group . An excellent result built first and foremost on the strength of our core business , complemented by the growing contribution of the new Business Units , as well as the progress achieved through the ongoing integration of Akern , which is making a positive contribution to the Group's overall performance . The investments made are progressively entering a phase of full value realization . Their contribution is becoming increasingly evident and significant , and , above all , they offer substantial potential for Pharmanutra S.p.A. Via Campodavela , 1 - 56122 Pisa | +39 050 7846500 pharmanutragroup.com | pharmanutra.it | info@pharmanutra.it | pharmanutra@pec.it C.F./P.Iva / Reg . Impr . 01679440501 - Codice SDI SUBM70N | Cap . Soc . € 1.123.097,70 I.V. | REA 146259 PHARMANUTRA group AEO SGS SGS PHARMANUTRA PHARMANUTRA PHARMANUTRA ESPAÑA USA YSTEM SGS FARMINDUSTRIA l'informazione Scientifica www.sgs.com ATHLETICA AKERN Cetilar